ASSESSMENT OF ADVERSE DRUG REACTIONS OF ANTIDEPRESSANT DRUGS USED IN PSYCHIATRY DEPARTMENT OF A TERTIARY CARE HOSPITAL

VIRENDRA KUSHWAHA; POOJA AGRAWAL; SARITA SINGH; DHANANJAY CHAUDHARY; AMIT K. VERMA; HIMANSHU SHARMA

doi:10.22159/ajpcr.2022.v15i4.44287

Authors

VIRENDRA KUSHWAHA Department of Pharmacology, Ganesh Shankar Vidyarthi Memorial Medical College, Kanpur, Uttar Pradesh, India.
POOJA AGRAWAL Department of Pharmacology, Ganesh Shankar Vidyarthi Memorial Medical College, Kanpur, Uttar Pradesh, India.
SARITA SINGH Department of Pharmacology, Ganesh Shankar Vidyarthi Memorial Medical College, Kanpur, Uttar Pradesh, India.
DHANANJAY CHAUDHARY Department of Psychiatry, Ganesh Shankar Vidyarthi Memorial Medical College, Kanpur, Uttar Pradesh, India.
AMIT K. VERMA Department of Pharmacology, Ganesh Shankar Vidyarthi Memorial Medical College, Kanpur, Uttar Pradesh, India.
HIMANSHU SHARMA Department of Pharmacology, Ganesh Shankar Vidyarthi Memorial Medical College, Kanpur, Uttar Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i4.44287

Keywords:

Depression, Antidepressants., Non –compliance, Naranjo’s Scale

Abstract

Objective: The aim of the study was to analyze adverse drug reactions (ADRs) reported in patients prescribed antidepressants at tertiary care hospital.

Methods: A prospective and observational study was conducted during January 2020–July 2021 at Department of Pharmacology in collaboration with the Department of Psychiatry, GSVM Medical College, and Kanpur. All patients diagnosed with depression and receiving pharmacotherapy were included in the study. ADRs were monitored using the standard form of the Central Drugs Standard Control Organization and causality was determined using the Naranjo algorithm. Data were evaluated for patient’s demography, risk factors for ADRs, and pattern of ADR.

Results: A total of 293 ADRs were recorded from 110 patients. The most common ADRs observed were anxiety (47.42%) and insomnia (19.22%). Men (58.18%) were most commonly affected than women (41.82%). The most common causal drugs among antidepressants were Escitalopram (27.27%) and Venlafaxine (21.81%), respectively. The most common system involved was central nervous system (53.24%) followed by gastrointestinal system (41.63%). The majority of ADRs (97.95%) were possible according to the Naranjo’s scale.

Conclusion: Anxiety, insomnia, and dizziness were the common ADRs which were associated with the use of antidepressants. This study offers a representative profile of the ADRs which can be expected in the psychiatry outpatients.

Downloads

Download data is not yet available.

References

Martínez A. A Way of Bridging the Gap between Psychological Treatments and Antidepressant Medication. Int J Depress Anxiety 2019;2:010. doi: 10.18203/2319-2003.ijbcp20150366

Koirala B, Rauniar G, Shakya D. Adverse effects including sexual problems associated with the use of selective serotonin reuptake inhibitors in a tertiary care center of Eastern Nepal. Int J Basic Clin Pharmacol 2015;4:651-6.

World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates. Geneva: World Health Organization; 2017.

World Health Organization. Preventing Suicide: A Global Imperative. Geneva: World Health Organization; 2014.

Harichandran DT, Viswanathan MT, Gangadhar R. Adverse drug reactions among hospitalized patients in Psychiatry Department in a Tertiary Care Hospital. J Health Res Rev 2016;3:77-80. doi: 10.18203/2319-2003.ijbcp20150366

Rauniar GP, Panday DR. Adverse drug reaction (ADR) monitoring at the Eastern Regional Pharmacovigilance Centre, Nepal. Kathmandu Univ Med J (KUMJ) 2017;15:296-300. doi: 10.4103/2394-2010.184243

Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res 2011;2:129-36. PMID 30580345

Barvaliya S, Panchal JR, Desai MK, Parikh M. Pattern of adverse drug reactions into psychiatric patients. Int J Basic Clin Pharmacol 2019;8:1059. doi: 10.4103/2229-3485.86883, PMID 22145123

Shah A, Yadav PP, Chaudhari M, Vataliya A, Kantharia ND, Mehta R. A prospective study of adverse drug reactions in patients with bipolar disorder in psychiatry outpatient department of a tertiary care hospital. J Clin Diagn Res 2017;11:FC24-8. doi: 10.18203/2319-2003. ijbcp20191601

Sengupta G, Bhowmick S, Hazra A, Datta A, Rahaman M. Adverse drug reaction monitoring in psychiatry out-patient department of an Indian teaching hospital. Indian J Pharmacol 2011;43:36-9. doi: 10.7860/JCDR/2017/24009.9873, PMID 28658799

Prajapati HK, Joshi ND, Trivedi HR, Parmar MC, Jadav SP, Parmar DM, et al. Adverse drug reaction monitoring in psychiatric outpatient department of a tertiary care hospital. Depression 2013;63:15-48. doi: 10.4103/0253-7613.75664, PMID 21455419

Sriram S, Ghasemi A, Ramasamy R, Devi M, Balasubramanian R, Ravi TK, et al. Prevalence of adverse drug reactions at a private tertiary care hospital in south India. J Res Med Sci 2011;16:16-25.

Bruton LL, Hilal-Dandan R, Knollmann BC. Goodman and Gilman’s the Parmacological Basis of Therapeutics. 13th ed. Unites States of America: McGraw Hill Education; 2018. p. 268, 269, 270, 271.

Fasipe OJ. The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents. IBRO Rep 2019;6:95-110.

Beardslee WR, Hoke L, Wheelock I, Rothberg PC, van de Velde P, Swatling S. Initial findings on preventive intervention for families with parental affective disorders. Am J Psychiatry 1992;149:1335-40. doi: 10.1016/j.ibror.2019.01.001, PMID 31211282

Driessen M, Schulz P, Jander S, Ribbert H, Gerhards S, Neuner F, et al. Effectiveness of inpatient versus outpatient complex treatment programs in depressive disorders: A quasi-experimental study under naturalistic conditions. BMC Psychiatry 2019;19:380. doi: 10.1176/ ajp.149.10.1335, PMID 1530069

Tandon VR, Mahajan V, Khajuria V, Gillani Z. Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India. Indian J Pharmacol 2015;47:65-71. doi: 10.1186/s12888-019-2371-5, PMID 31791279

Lucca JM, Madhan R, Gurumurthy P, Dushad R. A prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in India. Indian J Pharmacol 2014;46:543-6. doi: 10.4103/0253-7613.150344, PMID 25821314

Sankhi S, Marasine NR, Sankhi S, Lamichhane R. Adverse drug reaction due to antidepressants among patients with depression in a private psychiatric hospital of Nepal. Biomed Res Int 2020;2020:6682928. doi: 10.4103/0253-7613.140591, PMID 25298586

Sridhar SB, Al-Thamer SS, Jabbar R. Monitoring of adverse drug reactions in psychiatry outpatient department of a Secondary Care Hospital of Ras Al Khaimah, UAE. J Basic Clin Pharm 2016;7:80-6.

Patel TK, Bhabhor PH, Desai N, Shah S, Patel PB, Vatsala E, et al. Adverse drug reactions in a psychiatric department of tertiary care teaching hospital in India: Analysis of spontaneously reported cases. Asian J Psychiatr 2015;17:42-9. doi: 10.4103/0976-0105.183263,PMID 27330260

Rajesh R, Vidyasagar S, Nandakumar K. RETRACTED by plagiarism: Highly active antiretroviral therapy induced adverse drug reactions in Indian human immunodeficiency virus positive patients. Pharm Pract (Granada) 2011;9:48-55. doi: 10.1016/j.ajp.2015.07.003, PMID 26216702

Bhavani KB, Hema NG, Sangeetha. A prospective observational study of adverse drug reactions to antidepressants: Type and risk factors in a tertiary care teaching hospital. Int J Basic Clin Pharmacol 2014;3:380- 4.

Modayil RR, Harugeri A, Parthasarathi G, Ramesh M, Prasad R, Naik V, et al. Adverse drug reactions to antidepressants. An experience of spontaneous reporting and intensive monitoring from centers in India. Pharmacoepidemiol Drug Saf 2010;19:247-55.

Aburamadan, Sridhar S, Tadross T. Adverse drug reactions to antipsychotic medications, intensive monitoring of adverse drug reactions to antipsychotic medications in the inpatient psychiatry department of a secondary care hospital of UAE. Int J Pharm Investig 2018;8:151-6. doi: 10.1002/pds.1907, PMID 20066675

Grohmann R, Hippius H, Helmchen H, Rüther E, Schmidt LG. The AMUP study for drug surveillance in psychiatry – A summary of inpatient data. Pharmacopsychiatry 2004;37 Suppl 1:S16-26.

Mishra S, Swain TR, Mohanty M. Adverse drug reaction monitoring of antidepressants in the psychiatry outpatients department of a tertiary care teaching hospital. J Clin Diagn Res 2013;7:1131-4. doi: 10.1055/s- 2004-815507, PMID 15052511

Nagpal M, Tayal V, Kumar S, Gupta U. Adverse drug reactions in patients diagnosed with depression and were on antidepressants. Adv Pharm Technol Res 2012;3:62-7. doi: 10.7860/JCDR/2013/4985.3041, PMID 23905119

Atul J, Arpita S, Ajay V, Maneesh S. Assessment of awareness towards pharmacovigilance program of India and reporting of adverse drug reactions among nurses in a tertiary care hospital. Int J Basic Clin Pharmacol 2018;7:1357-64.

Gummadi T, Harave VS, Aiyar LN, RajaLekshmi SG, Kunnavil R. Adverse drug reaction monitoring in a tertiary care psychiatry setting: A comparative study between inpatients and outpatients. Indian J Psychol Med 2017;39:306-11. doi: 10.4103/0253-7176.207328, PMID 28615765.